V1 - 082807 www.bakernet.com May 26 – 27 2008 Thomas DEVRED Baker & McKenzie - Paris The International Medical Devices Compliance Congress and Best Practices.

Slides:



Advertisements
Similar presentations
Understanding Private Payers & Maximizing Private Payer Reimbursement Strategies: Understanding the Process Barbara Grenell, Preferred Health Strategies.
Advertisements

Framework Guideline on gas capacity allocation Stefanie Neveling, Co-Chair CAM TF 20 th Madrid Forum, 27 September 2011.
Basic Nursing: Foundations of Skills & Concepts Chapter 6 LEGAL RESPONSIBILITIES.
GCP compliance for GenISIS  This presentation is intended for clinical staff involved in recruiting patients to the GenISIS (Genetics of Influenza Susceptibility.
THE FIRST INTERNATIONAL MEDICAL DEVICE COMPLIANCE CONGRESS Global Device Codes of Ethics/Conduct Roundtable Paris, France May 27, 2008 Philippe Laroche.
Use of Children as Research Subjects What information should be provided for an FP7 ethical review?
OFFICE OF INSURANCE REGULATION CURRENT STATE OF DISCOUNT MEDICAL PLAN ORGANIZATIONS (DMPOs) IN FLORIDA FLORIDA OFFICE OF INSURANCE REGULATION.
Internal Control and Internal Audit
Business Law Unit 1 Law, Justice, and You
Geldy Saryev Head of Industry, Transport and Communications Financing Department of the Ministry of Finance of Turkmenistan.
Procurement Presentation Alan Brett Contracts Officer HSE.
2012 AASBO Summer Conference Insurance Pools as an Option in the Quest To Purchase Health Insurance Effectively Bill Munch, VSMG Ken Carter,
Are you ready for a recall? Medical Device Regulatory, Reimbursement and Compliance Congress March 28, 2007 Willie R. Bryant, Jr. Consultant Stericycle,
Pharmacy and Therapeutics Committee
The Third Annual Medical Device Regulatory, Reimbursement and Compliance Congress Compliance Best Practices in a Post Orthopedic Environment David Matyas.
HSP progress in Taiwan 2009 Benjamin I. Kuo, MD, DrPH, CIP Secretariat, Joint Institutional Review Board.
Audit of Public Procurement
Verification Analyst Qualifications Verification Agencies Workshop 5-8 September 2006 Facilitator: Theo Lombard.
”The tool-kit of TI in fighting corruption in the business sector” BALTIC-NORDIC CONFERENCE ON BUSINESS ETHICS Tallin, April Arvid Halvorsen Member.
Voluntary Codes MassMEDIC Meeting Are You Ready to Comply with Massachusetts’ New Pharmaceutical and Medical Device Code of Conduct Law? Linda D. Bentley,
Scientific Expertise of Draft Normative Legal Acts in the Field of Finance within the Framework of Implementation of the Legal Policy of Kazakhstan Yuliya.
NORTH AMERICAN HEALTHCARE INFORMED CONSENT. RESIDENT RIGHTS Make decisions Accept or refuse treatment Be free from any physical/chemical restraints Receive.
K RIEL C OLLIERY Anglo Coal Contractor Management.
PROCUREMENT OVERSIGHT AND MONITORING – A MEANS FOR EFFECTIVE PROJECT IMPLEMENTATION 11 th PUBLIC PROCUREMENT KNOWLEDGE EXCHANGE FORUM June, 9-12, 2015.
Medical Device Compliance Congress: Emerging Compliance Issues in Asia Anne Trimmer.
EMS Law Chapter 16. Copyright © 2007 Thomson Delmar Learning Objectives Identify the tools that a state health agency responsible for emergency medical.
THE FIRST INTERNATIONAL MEDICAL DEVICE COMPLIANCE CONGRESS May , 2008 Paris Marriott Rive Gauche Hotel and Conference Center Paris, France Joachim.
Disciplinary measures taken in cases of medical misconduct in the EU Member States Konstanty Radziwill CPME, Ethics and professional codes Subcomitee,
A Focus on CME and Grants Nancy Coddington, PhD Senior Director, Compliance Operations AstraZeneca Pharmaceuticals LP And Terry Hisey Deputy Managing Principal.
State of implementation of the decision III/6f regarding Ukraine (MOP 2, June, , 2008, Riga, Latvia)
Biobanks for research. Ethical and regulatory aspects in human biological samples collections in France Christine NOIVILLE CNRS / Paris 1 University.
New Rules for Clinical Investigations in Germany
1 Harvard University Cambridge, MA March 29, 2007 Medical Device Congress AdvaMed’s Efforts to Promote Compliance Christopher L. White, Esq. Executive.
Public Procurement Uinsinn Finn Galway County Council Roads, Transportation, Marine.
Informed Consent Maria Lorentzon Tzu-Chuan Liao Bryan Keane.
Legal Terminology Biomedical Technology Legal implications in health care  Malpractice: harmful, incorrect, or negligent practice or treatment of a.
The Third Annual Medical Device Regulatory, Reimbursement and Compliance Congress 1 How to Implement a Private Payer Reimbursement Strategy Barbara Grenell.
Introduction, purpose and General Rules for Documentation Dr. Ali Abd El-Monsif Thabet.
Connecting for Health Common Framework: the Model Contract for Health Information Exchange Gerry Hinkley com July 18, 2006 Davis Wright.
LATVENERGO GROUP COMPLIANCE AND FRAUD RISK MANAGEMENT Kristine Arensone Compliance officer
In September of 2012 the RA Government made amendments in the Resolution No 168 on ‘Regulation of Procurement Procedures". 1. It is the responsibility.
INVITATION TO TENDER PROCEDURE INVITATION TO TENDER PROCEDURE IT–4144/SMB/HL-LHC (Point 1) IT-4155/SMB/HL-LHC (Point 5)
Peter Lukáč Ministry of Environment of the Slovak Republic Department of Environmental Assessment.
Lecturer: Lina Vladimirovna Zhornyak, associated professor.
Health and Food Safety EU strategy for Pharmaceuticals in the Environment Patrizia Tosetti DG SANTE European Commission China/EU Pharmaceutical Industry.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 2– Freedom Movement for Workers Bilateral.
UNITS 4:3-4:4 Patients’ Rights and Legal Directives for Health Care.
Transparency of payments to healthcare professionals: ABPI plans for a central platform for individual disclosures 2016 June 2014.
REPUBLIC OF ALBANIA PUBLIC PROCUREMENT AGENCY Eighth Regional Public Procurement Forum May, 22-25, 2012 Tirana
Ethical and Legal Issues Chapter 3. Ethics  Ethics – the study of morals; reflects standard Medical ethics has been important to medicine since 400 B.C.
Best Practices in Navigating Emerging ASC Legal Challenges Carol K. Lucas, Esq
Improving Compliance with ISAs Presenters: Al Johnson & Pat Hayle.
Good Clinical Practice (GCP) and Monitoring Practices
Public Procurement Agency - Bulgaria
Unit for Medical Systems and Devices at Ministry of Health
Prop 106 (End-of-Life Options Act) and Hospital Implications
Enrolling in Clinical Trials
Office of Legal Affairs
Presentation to the Portfolio Committee on Finance
Chapter 20 Additional Assurance Services: Other Information
The Emergency Medical Treatment and Active Labor Act
Canadian Auditing Standards (CAS)
AGREEMENT FOR TRANSPARENCY The Case of Mexico
The European Anti-Corruption Report
Biomedical Technology
What Healthcare Providers Are Doing to Promote Regulatory Compliance
Prescription-only vs. over-the-counter medicines
REGIONAL WORKSHOP ON WHISTLEBLOWER PROTECTION IN SECURITY SECTOR
CF Canada Financial Group
Presentation transcript:

v May 26 – Thomas DEVRED Baker & McKenzie - Paris The International Medical Devices Compliance Congress and Best Practices Forum The new Italian and French Compliance Laws ETHICAL CONTROL OF PHYSICIANS

2 Legal framework  1993 « Anti-Gift » Act  HCPs legislation (not pharma legislation)  Application Decree: 25 March 2007  Recent guidelines: Work Document adopted by Leem, SNITEM and CNOM: 21 June 2007

3 Anti-Gift Act  HCPs are prohibited from receiving any pecuniary advantages or benefits in kind from companies producing or commercializing Rx products

4 Ethical control: by physicians  In addition to the self-regulatory control of health products companies  Prior Control by the Professional Association of Physicians:  CNOM (national level)  CDOM (regional level: districts)  Level of control: opinion (not approval)

5 Scope  Contracts relating to research activity and/or scientific evaluation and  Hospitality (invitations to congresses, symposia or other events)

6 Procedure  Application for opinion submitted by the company, at least:  For contracts: 2 months before the « effective date »  For hospitality: 1month before the date of the event

7 Examination  CNOM examines the level of remuneration, which must:  Be proportionate to the services provided by the physicians (contracts)  Remain reasonable (hospitality)  For research contracts other than clinical trial contracts: CNOM also examines the protocols/methodologies

8 Opinion addressed to the company  If negative: the company must inform the physician(s)  The CNOM decision is an opinion, i.e. not binding  A decision must be taken (risk assessment)

9 Sanctions  Non compliance with the anti-gift law can trigger criminal sanctions:  Against individuals (both the physician and the manager of the company) : fine (up to € ) + imprisonment (up to 2 years)  Against companies (as legal entities): fine (up to € ) + possible prohibition from presenting offers in bid procedures for procurement contracts with public hospitals

10 Some figures (2006)*  Hospitality:  applications / Negative opinions: 5-10 %  Clinical Trial Contracts:  applications / Negative opinion: 3-5 %  Other Contracts:  500 applications / Negative Opinions: 10% * Dr Chanu: President of the Section « relationships with industries » - CNOM